Department of International Affairs
Click to view timeline
Timeline
Projects
Former Teams
Publications
Download-
2015Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant, J. Acquir. Immune Defic. Syndr. 2015 Apr;68(5):487-94.
-
2015Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients, Sci Transl Med 2015 Apr;7(283):283ra55.
-
2015Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin, Cancer Res. 2015 Apr;75(8):1603-14.
-
2015Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer, Autophagy 2015;11(10):1878-90.
-
2014A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals, J. Acquir. Immune Defic. Syndr. 2014 Jun;66(2):140-7.
-
2013Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists, Cell Death Differ. 2014 Jan;21(1):69-78.
-
2013Current trends of anticancer immunochemotherapy, Oncoimmunology 2013 Jun;2(6):e25396.
-
2013Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort, Oncoimmunology 2013 Mar;2(3):e23472.
-
2010Novel integrase inhibitors for HIV, Expert Opin Investig Drugs 2010 Sep;19(9):1087-98.
-
2009Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors, Antimicrob. Agents Chemother. 2009 Oct;53(10):4275-82.
-
+View full list of publications